| Medical and Health Sciences | 2021-2025 | 133 | ES 5 | 99.98 |
| Reproductive Medicine | Lifetime | 97 | ES 5 | 99.45 |
| Obstetrics and Gynecology | Lifetime | 111 | ES 3 | 99.34 |
| Obstetrics and Gynecology | 2021-2025 | 3 | ES 1 | 99.93 |
| Reproductive Medicine | 2021-2025 | 3 | ES 1 | 99.90 |
| Public, Environmental and Occupational Health | 2021-2025 | 147 | ES 4 | 98.73 |
| Surgery | 2021-2025 | 547 | ES 4 | 95.48 |
| Epidemiology | 2021-2025 | 647 | ES 16 | 93.93 |
| Pediatrics, Perinatology and Child Health | 2021-2025 | 369 | ES 5 | 91.75 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 532 | ES 11 | 81.68 |
| Rheumatology | 2021-2025 | 483 | ES 10 | 72.87 |
| Endometriosis Research and Treatment | Lifetime | 52 | ES 3 | 99.45 |
| Uterine Myomas and Treatments | Lifetime | 41 | ES 1 | 99.55 |
| Gynecological conditions and treatments | Lifetime | 38 | ES 2 | 99.29 |
| Reproductive System and Pregnancy | Lifetime | 205 | ES 5 | 98.67 |
| COVID-19 and healthcare impacts | Lifetime | 259 | ES 5 | 96.30 |
| Ovarian function and disorders | Lifetime | 247 | ES 13 | 98.73 |
| Ovarian cancer diagnosis and treatment | Lifetime | 403 | ES 7 | 98.27 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 385 | ES 8 | 98.12 |
| COVID-19 Impact on Reproduction | Lifetime | 163 | ES 1 | 95.91 |
| Reproductive Biology and Fertility | Lifetime | 875 | ES 38 | 97.70 |
| Pelvic floor disorders treatments | Lifetime | 908 | ES 11 | 96.12 |
| Assisted Reproductive Technology and Twin Pregnancy | Lifetime | 705 | ES 18 | 96.25 |
| Ectopic Pregnancy Diagnosis and Management | Lifetime | 324 | ES 2 | 95.98 |
| Intestinal and Peritoneal Adhesions | Lifetime | 397 | ES 12 | 93.88 |
| Gestational Trophoblastic Disease Studies | Lifetime | 247 | ES 2 | 92.20 |
| Maternal and fetal healthcare | Lifetime | 871 | ES 4 | 94.39 |
| Pregnancy-related medical research | Lifetime | 717 | ES 9 | 92.70 |
| Minimally Invasive Surgical Techniques | Lifetime | 684 | ES 15 | 88.95 |
| Endometriosis Research and Treatment | 2021-2025 | 1 | ES 1 | 99.88 |
| Uterine Myomas and Treatments | 2021-2025 | 1 | ES 1 | 99.91 |
| Gynecological conditions and treatments | 2021-2025 | 1 | ES 1 | 99.89 |
| Ovarian function and disorders | 2021-2025 | 13 | ES 1 | 99.33 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 21 | ES 2 | 99.50 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 34 | ES 3 | 99.26 |
| Reproductive Biology and Fertility | 2021-2025 | 54 | ES 4 | 98.68 |
| COVID-19 and healthcare impacts | 2021-2025 | 95 | ES 1 | 97.65 |
| Reproductive System and Pregnancy | 2021-2025 | 36 | ES 3 | 98.10 |
| Cervical Cancer and HPV Research | 2021-2025 | 68 | ES 2 | 97.89 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 11 | ES 1 | 95.66 |
| COVID-19 Impact on Reproduction | 2021-2025 | 99 | ES 2 | 95.84 |
| Pregnancy-related medical research | 2021-2025 | 49 | ES 2 | 94.46 |
| Ectopic Pregnancy Diagnosis and Management | 2021-2025 | 40 | ES 1 | 95.01 |
| Minimally Invasive Surgical Techniques | 2021-2025 | 21 | ES 2 | 93.59 |
| Gestational Trophoblastic Disease Studies | 2021-2025 | 21 | ES 1 | 92.51 |
| Pregnancy and preeclampsia studies | 2021-2025 | 503 | ES 16 | 93.71 |
| Assisted Reproductive Technology and Twin Pregnancy | 2021-2025 | 193 | ES 7 | 93.20 |
| Gestational Diabetes Research and Management | 2021-2025 | 327 | ES 6 | 92.00 |
| Maternal and fetal healthcare | 2021-2025 | 235 | ES 1 | 93.11 |
| Pelvic floor disorders treatments | 2021-2025 | 970 | ES 30 | 84.41 |
| Menopause: Health Impacts and Treatments | 2021-2025 | 156 | ES 11 | 83.04 |
| Intraperitoneal and Appendiceal Malignancies | 2021-2025 | 450 | ES 23 | 82.52 |
| Pregnancy and Medication Impact | 2021-2025 | 526 | ES 5 | 81.05 |
| Cancer Risks and Factors | 2021-2025 | 759 | ES 18 | 77.35 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 606 | ES 27 | 78.40 |
| Reproductive Health and Technologies | 2021-2025 | 958 | ES 21 | 77.55 |
| Enhanced Recovery After Surgery | 2021-2025 | 741 | ES 14 | 69.29 |
| Ureteral procedures and complications | 2021-2025 | 987 | ES 33 | 62.37 |
| Phytoestrogen effects and research | 2021-2025 | 778 | ES 23 | 51.78 |